SuicideNCT07072819

Pilot of Training on 988 and Narcan

A study testing Crisis Ready Training in people with Suicide and Overdose Accidental, run by RAND at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record

Search all trials

Trial summary

This pilot study evaluates the acceptability, appropriateness, and feasibility of a new crisis response training called Crisis Ready. Read more about this study

Who is it for?: Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for: Suicide, Overdose Accidental, Overdose Antidote
What is being tested?: Crisis Ready Training
Type of treatment: Lifestyle or therapy programme
Could I receive a placebo?: No, everyone receives an active treatment
How many people: 27 participants
Where: 1 siteUnited States
Study dates: 12 Jun 2025to 31 Jul 2025
Phase: Interventional
Are there results?: Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

Ages 18 years and older
All sexes
Healthy volunteers accepted
Adult, Older adult

Who may be able to join

Participates in the Baltimore Crisis Response, Inc Law Enforcement Assisted Diversion Program
Capacity to give informed consent

Who cannot join

Unable to understand English

Trial locations and contacts

1 site in 1 country.

United States1 site

Baltimore Crisis Response, Inc.
Baltimore, Maryland, 21201

Other trials in United States

About this study

Official title: Safer Diversion: Adapting Scalable Crisis Response Interventions for People Involved in a Criminal Legal System Diversion Program

This pilot study evaluates the acceptability, appropriateness, and feasibility of a new crisis response training called Crisis Ready.

Read the detailed description

The study team conducted formative work to develop a new crisis response training for people involved in a law-enforcement assisted diversion program. The training, called Crisis Ready, combines an intervention that aims to promote use of 988 with a training on the use of Naloxone to reverse and overdose. The pilot aims to collect quantitative and qualitative data about the perceptions of the training among program participants and program staff.

Conditions: Suicide, Overdose Accidental, Overdose Antidote, Crisis Response Plan
Being tested: Crisis Ready Training
Keywords: suicide, overdose, 988, naloxone
Medical subject headings: Suicide, Drug Overdose

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Crisis Ready TrainingBehavioural
Crisis Ready Training combines Crisis Line Facilitation with Take Home Naloxone training. The intervention is delivered in a group format.

Study groups in NCT07072819
Study group	Role	What they receive
Crisis Ready Training	Experimental	This is an open label pilot of a new psychoeducational Intervention called the Crisis Ready Training. The intervention combines Crisis Line Facilitation and Take Home Naloxone trainings. Receives: Behavioral: Crisis Ready Training

What is being measured

The primary outcome is the main question the study is designed to answer.

Acceptability of Intervention Measure
Participants' perspectives of the likability of the intervention. Scores range from 4 to 20, with higher scores indicating higher levels of acceptability.
Measured: Post-intervention (approximately 90 minutes on one day)
Intervention Appropriateness Measure
Measures the fit of the intervention for the population. Scores range from 4 to 20 with higher scores indicating higher levels of appropriateness.
Measured: Post-intervention (approximately 90 minutes on one day)

Secondary outcomes (5)

Perceptions of the Crisis Ready Training
Participants rating of the quality of Crisis Ready and willingness to recommend the intervention to others
Measured: Post-intervention (approximately 90 minutes on one day)
Attitudes About 988
Two-item assessments of comfort using 988 for oneself or others during a crisis. Responses are gathered from a Likert-type scale that ranges from 0 (not comfortable at all) to 10 (totally comfortable). Higher scores indicate higher levels of comfort using 988 for self or others.
Measured: Post-intervention (approximately 90 minutes on one day)
Perception of 988
Perceptions of 988 utilization and couneslors
Measured: Post-intervention (approximately 90 minutes on one day)
Knowledge of Naloxone
Author created measure of knowledge about how to administer naloxone and where to obtain naloxone.
Measured: Post-intervention (approximately 90 minutes on one day)
Attitudes About Naloxone
Four-item, author developed measures about comfort carrying and using naloxone in different circumstances. Responses are gathered from a Likert-type scale that ranges from 0 (not comfortable at all) to 10 (totally comfortable). Higher scores indicate higher levels of comfort carrying and using naloxone in different circumstances.
Measured: Pre- and Post-intervention (approximately 90 minutes on one day)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

12 Jun 202531 Jul 2025

First posted18 Jul 2025
Study start12 Jun 2025
Primary completion31 Jul 2025
Study completion31 Jul 2025

Resources

Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
Other trials for SuicideStudies of the same condition, open and under way.
What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design

Study type: Interventional
Phase: Phase N/A
Primary purpose: Prevention
Allocation: Not applicable
Intervention model: Single group
Masking: None (open label)
Enrolment: 27 participants (actual)

IDs, dates and publications

ClinicalTrials.gov ID: NCT07072819
Sponsor's protocol ID: 2024-N0187
Status last verified: Jun 2026
First submitted: 25 Jun 2025
Last updated: 30 Jun 2026
Results posted: Yes, on ClinicalTrials.gov
Data monitoring committee: No
FDA-regulated drug: No
FDA-regulated device: No
Individual data sharing: Yes: De-identified quantitative data will be stored and shared by The National Center for Health and Criminal-Legal Systems Integration for Suicide Prevention.

Want to know more?

The sponsor has not listed a contact. The official record may have more details.

Talk to your doctor first and take this page with you. Only the study team can confirm whether you can join.

Questions to ask the study team

What is the study trying to find out?
What would I need to do, and how often would I visit?
Could I receive a placebo instead of the treatment?
What are the possible risks and benefits for me?
Will it cost me anything? Are travel or time paid for?
Can I keep seeing my own doctor during the study?
What happens when the study ends?

See locations

Not yet recruiting
A Pre-post Study of a Lethal Means Safety Planning Intervention for Youth at Elevated Suicide Risk in the Emergency Department
Suicidal Ideas, Suicidal Ideation
RecruitingObservational study
Student Precarity and Psychiatry
Depressive Disorder, Major, Generalized Anxiety Disorder
Not yet recruiting
SERENE Low-Intensity Focused Ultrasound for Cognitive Control
Suicidal Ideation, Cognitive Control
Not yet recruiting
A MRT to Optimize a JITAI for Alcohol Craving and Suicide Ideation
Alcohol Use Disorder (AUD), Suicide Ideation
Enrolling by invitation
Pilot Study of a Modified Safety Planning Intervention for Elementary School-Aged Children - Main Study
Suicidal Ideation, Suicidal Behaviors

All Suicide trials

Study at a glance

From the registry record, last updated by the sponsor on 30 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.

Official title: Safer Diversion: Adapting Scalable Crisis Response Interventions for People Involved in a Criminal Legal System Diversion Program
ClinicalTrials.gov ID: NCT07072819
Acronym / sponsor ID: 2024-N0187
Conditions: Suicide, Overdose Accidental, Overdose Antidote, Crisis Response Plan
Keywords: suicide, overdose, 988, naloxone
Study type: Interventional
Recruitment status: Completed
Enrolment: 27 participants (actual)
Lead sponsor: RANDUniversity, hospital or other
Collaborators: Henry Ford Health + Michigan State University Health Sciences, Brown University
Study start: 12 Jun 2025 (actual)
Primary completion: 31 Jul 2025 (actual)
Study completion: 31 Jul 2025 (actual)
First posted: 18 Jul 2025 (actual)
Results: Posted 13 Mar 2026

Clinical summary

The research question as the sponsor registered it. This describes what the study plans to test, not what it found.

This pilot study evaluates the acceptability, appropriateness, and feasibility of a new crisis response training called Crisis Ready.

Detailed description

Study design

Primary purpose: Prevention
Allocation: Not applicable
Intervention model: Single group
Masking: None (open label)
Number of arms: 1

Arm	Type	Receives
Crisis Ready Training	Experimental	Behavioral: Crisis Ready TrainingThis is an open label pilot of a new psychoeducational Intervention called the Crisis Ready Training. The intervention combines Crisis Line Facilitation and Take Home Naloxone trainings.

Who may qualify

Ages: 18 years and older
Sex: All
Healthy volunteers: Accepted
Age groups: Adult, Older adult

Key inclusion criteria (2 listed)

Participates in the Baltimore Crisis Response, Inc Law Enforcement Assisted Diversion Program
Capacity to give informed consent

Key exclusion criteria (1 listed)

Unable to understand English

Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.

Interventions

Intervention	Type	Arms
Crisis Ready TrainingCrisis Ready Training combines Crisis Line Facilitation with Take Home Naloxone training. The intervention is delivered in a group format.	Behavioural	Crisis Ready Training

Primary outcome

Acceptability of Intervention Measure
Time frame: Post-intervention (approximately 90 minutes on one day)
Participants' perspectives of the likability of the intervention. Scores range from 4 to 20, with higher scores indicating higher levels of acceptability.
Intervention Appropriateness Measure
Time frame: Post-intervention (approximately 90 minutes on one day)
Measures the fit of the intervention for the population. Scores range from 4 to 20 with higher scores indicating higher levels of appropriateness.

5 secondary outcomes

Perceptions of the Crisis Ready Training
Time frame: Post-intervention (approximately 90 minutes on one day)
Attitudes About 988
Time frame: Post-intervention (approximately 90 minutes on one day)
Perception of 988
Time frame: Post-intervention (approximately 90 minutes on one day)
Knowledge of Naloxone
Time frame: Post-intervention (approximately 90 minutes on one day)
Attitudes About Naloxone
Time frame: Pre- and Post-intervention (approximately 90 minutes on one day)

Results and safety

Results posted to the registry on 13 Mar 2026, as reported by the sponsor. Figures are copied from the record, not re-analysed. Full results on ClinicalTrials.gov.

Participant flow

Group	Started	Completed
Crisis Ready Training	27	23

Primary outcome: Acceptability of Intervention Measure

Time frame: Post-intervention (approximately 90 minutes on one day). Mean (Standard Deviation). Unit: units on a scale

Measure	Crisis Ready Training n = 23
Value	17.74 (2.42)

Population analysed: Participants in an open-label pilot of Crisis Ready

Primary outcome: Intervention Appropriateness Measure

Time frame: Post-intervention (approximately 90 minutes on one day). Mean (Standard Deviation). Unit: units on a scale

Measure	Crisis Ready Training n = 23
Value	17.91 (2.39)

Population analysed: Participants in an open-label pilot of Crisis Ready

5 secondary outcomes are reported in the full results.

Adverse events

Time frame: Pre- and Post-intervention (approximately 90 minutes on one day). Other adverse events reported at 0% frequency or more

Group	Serious adverse events	Other adverse events	Deaths
Crisis Ready Training	0 of 23 (0%)	0 of 23 (0%)	0 of 23

Limitations and caveats (from the sponsor): This pilot study enrolled only 27 participants from one law enforcement assisted diversion program. Additionally, outcomes were observed only immediately after the intervention. Results should be interpreted in light of the small sample size, sampling bias, and lack of follow-up time points.

Loading the posted results from ClinicalTrials.gov…

Research links

Official record on ClinicalTrials.govLast updated by the sponsor 30 Jun 2026.
Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
Individual participant dataSharing planned: Yes. De-identified quantitative data will be stored and shared by The National Center for Health and Criminal-Legal Systems Integration for Suicide Prevention.

Related trials for Suicide

Not yet recruiting
A Pre-post Study of a Lethal Means Safety Planning Intervention for Youth at Elevated Suicide Risk in the Emergency Department
Suicidal Ideas, Suicidal Ideation
RecruitingObservational study
Student Precarity and Psychiatry
Depressive Disorder, Major, Generalized Anxiety Disorder
Not yet recruiting
SERENE Low-Intensity Focused Ultrasound for Cognitive Control
Suicidal Ideation, Cognitive Control
Not yet recruiting
A MRT to Optimize a JITAI for Alcohol Craving and Suicide Ideation
Alcohol Use Disorder (AUD), Suicide Ideation
Enrolling by invitation
Pilot Study of a Modified Safety Planning Intervention for Elementary School-Aged Children - Main Study
Suicidal Ideation, Suicidal Behaviors

Referral and contact

AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.

Alison J Athey, PhD principal investigator

RAND

Sapna Mendon-Plasek, PhD principal investigator

RAND

1 site in 1 country: see every site and its status.

Questions about this trial

What is this clinical trial studying?

A study testing Crisis Ready Training in people with Suicide and Overdose Accidental, run by RAND at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 13 Mar 2026). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Acceptability of Intervention Measure (time frame: Post-intervention (approximately 90 minutes on one day)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07072819.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jun 2026.